Company Filing History:
Years Active: 2010-2011
Title: Mitsuhiro Uchida: Innovator in Pharmaceutical Composition
Introduction
Mitsuhiro Uchida is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for various diseases. With a total of 2 patents, his work focuses on innovative solutions for allergic and inflammatory conditions.
Latest Patents
Uchida's latest patents include a pharmaceutical composition aimed at treating allergic ophthalmic diseases and allergic nasal diseases. This composition comprises a tricyclic triazolobenzazepine derivative, specifically 7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzazepine. The invention is designed to provide strong prophylactic and therapeutic effects with minimal side effects, making it suitable for topical applications. Another significant patent focuses on a method for treating inflammatory bowel diseases. This method involves administering a therapeutically effective amount of the same triazolobenzazepine derivative or its prodrug, which has shown effectiveness even in severe cases resistant to conventional treatments.
Career Highlights
Mitsuhiro Uchida is currently associated with Meiji Seika Kaisha, Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from various conditions.
Collaborations
Uchida collaborates with esteemed colleagues such as Takashi Shishikura and Yukari Hoshina, contributing to a dynamic research environment that fosters innovation.
Conclusion
Mitsuhiro Uchida's contributions to pharmaceutical inventions highlight his commitment to improving healthcare through innovative solutions. His patents reflect a deep understanding of complex medical challenges and a dedication to developing effective treatments.